Friday, October 5, 2018 - 16:03
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for September 2018 the Company recorded decrease of sales revenues of 7% compared to the same month of 2017, including 55% increase of domestic sales and a decrease of 28% of export sales.
Revenue in the third quarter of 2018 increases compared to the same period in 2017, respectively, by 5%, incl. 10% increase of sales for the domestic market and 2% increase in export sales. Successful work during the quarter contributes to reducing the rate of decline in revenue and for the first nine months of this year, revenues from sales of products decreased by 4% (8% as at 30.06.2018) compared to the same period of 2017, including 1% decrease of domestic sales and 6% decrease of export sales.